UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Drugs (New York, N.Y.), ISSN 0012-6667, 2008, Volume 68, Issue 8, pp. 1029 - 1036
Sirolimus, therapeutic use | Age related macular degeneration, treatment | Ranibizumab, therapeutic use | Pazopanib, therapeutic use | Bevasiranib, therapeutic use | Vatalanib, therapeutic use | Research and development | TG 100801, therapeutic use | Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | RNA, Small Interfering - genetics | Sirolimus - therapeutic use | Serpins - genetics | Nerve Growth Factors - genetics | Protein Kinase Inhibitors - therapeutic use | Humans | Angiogenesis Inhibitors - therapeutic use | Nicotinic Antagonists - therapeutic use | Eye Proteins - genetics | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | Macular Degeneration - drug therapy
Journal Article
2017, Advances in experimental medicine and biology, ISBN 3319501747, Volume 964., xiii, 312 pages
Book
The Journal of clinical investigation, ISSN 0021-9738, 12/2013, Volume 123, Issue 12, pp. 5119 - 5134
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Receptors, Adrenergic, alpha-2 - genetics | Guanabenz - therapeutic use | Reactive Oxygen Species | Receptor, Serotonin, 5-HT2A - genetics | Doxazosin - pharmacology | Humans | Photoreceptor Cells, Vertebrate - drug effects | Adrenergic alpha-Antagonists - therapeutic use | Macaca fascicularis | Adrenergic alpha-Antagonists - pharmacology | Molecular Targeted Therapy | Photoreceptor Cells, Vertebrate - physiology | Macular Degeneration - drug therapy | Adenylyl Cyclase Inhibitors | Adrenergic alpha-Agonists - therapeutic use | Alcohol Oxidoreductases - genetics | ATP-Binding Cassette Transporters - deficiency | Photoreceptor Cells, Vertebrate - radiation effects | ATP-Binding Cassette Transporters - genetics | Adenine - therapeutic use | Doxazosin - therapeutic use | Nerve Tissue Proteins - biosynthesis | Receptors, Adrenergic, alpha-2 - biosynthesis | Drug Evaluation, Preclinical | Disease Models, Animal | Macular Degeneration - prevention & control | Receptor, Serotonin, 5-HT2A - biosynthesis | Adenine - analogs & derivatives | Signal Transduction | Cell Survival | Light - adverse effects | Serotonin Antagonists - therapeutic use | Receptors, G-Protein-Coupled - biosynthesis | Adenine - pharmacology | Serotonin Antagonists - pharmacology | Nerve Tissue Proteins - genetics | Mice, Knockout | Guanabenz - pharmacology | Animals | Macular Degeneration - congenital | Macular Degeneration - genetics | Adrenergic alpha-Agonists - pharmacology | Mice | Mice, Inbred BALB C | Receptors, G-Protein-Coupled - genetics | Photoreceptor Cells, Vertebrate - pathology | Alcohol Oxidoreductases - deficiency | Macular degeneration | Retinal degeneration | Research | Studies | Pathology | Signal transduction | Disease | Genes | Retina | Photoreceptors | Pharmacology | Index Medicus | Abridged Index Medicus
Journal Article
Pain (Amsterdam), ISSN 0304-3959, 05/2019, Volume 160, Issue Suppl 1, pp. S17 - S22
Neurosciences | Clinical Neurology | Anesthesiology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurodegenerative Diseases - pathology | Cytoskeletal Proteins - antagonists & inhibitors | Humans | Enzyme Inhibitors - pharmacology | Axons - drug effects | Axons - metabolism | Neurodegenerative Diseases - metabolism | Neurodegenerative Diseases - drug therapy | Enzyme Inhibitors - therapeutic use | Nerve Degeneration - metabolism | Nerve Degeneration - pathology | Peripheral Nervous System Diseases - metabolism | Animals | Axons - pathology | Armadillo Domain Proteins - metabolism | Armadillo Domain Proteins - antagonists & inhibitors | Cytoskeletal Proteins - metabolism | Peripheral Nervous System Diseases - pathology | Nerve Degeneration - drug therapy | Peripheral Nervous System Diseases - drug therapy | Index Medicus | NAD | NMNAT2 | Sarmoptosis | DLK kinase | PHR1 ligase
Journal Article
Nature neuroscience, ISSN 1097-6256, 06/2008, Volume 11, Issue 6, pp. 649 - 658
Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Axotomy - methods | Nerve Degeneration - physiopathology | Visual Pathways - metabolism | Nerve Degeneration - genetics | Neurons - cytology | Axons - physiology | Green Fluorescent Proteins - genetics | Receptor, Nerve Growth Factor - deficiency | Dose-Response Relationship, Drug | Brain-Derived Neurotrophic Factor - pharmacology | Drug Interactions | Brain-Derived Neurotrophic Factor - physiology | Potassium Chloride - pharmacology | Gene Expression Regulation, Developmental - physiology | Animals, Newborn | Stilbamidines - metabolism | Superior Cervical Ganglion - growth & development | Cholera Toxin - metabolism | Visual Pathways - growth & development | Mice, Inbred C57BL | Cells, Cultured | Enzyme Inhibitors - pharmacology | Gene Expression Regulation, Developmental - drug effects | Receptor, Nerve Growth Factor - physiology | Axons - drug effects | Nerve Growth Factor - pharmacology | Rats | Mice, Transgenic | Superior Cervical Ganglion - cytology | Rats, Sprague-Dawley | Animals | Green Fluorescent Proteins - biosynthesis | Mice | Nerve Degeneration - drug therapy | Brain-derived neurotrophic factor | Physiological aspects | Nervous system | Degeneration | Research | Growth factor receptors | Risk factors | Index Medicus
Journal Article
6.
Full Text
Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy
Neuropharmacology, ISSN 0028-3908, 10/2016, Volume 109, pp. 69 - 77
Impulsivity | Substantia nigra | Parkinson | Alpha-synuclein | Pramipexole | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Dopamine Agonists - pharmacology | Substantia Nigra - pathology | Dopaminergic Neurons - pathology | Dopamine Agonists - therapeutic use | Impulsive Behavior - drug effects | Conditioning, Operant - physiology | Rats | Male | Parkinson Disease - drug therapy | Substantia Nigra - metabolism | Rats, Sprague-Dawley | Nerve Degeneration - chemically induced | Nerve Degeneration - metabolism | Nerve Degeneration - pathology | Substantia Nigra - drug effects | Animals | Conditioning, Operant - drug effects | Dopaminergic Neurons - metabolism | Dopamine Agonists - toxicity | Dopaminergic Neurons - drug effects | Parkinson Disease - metabolism | Impulsive Behavior - physiology | Dopamine - metabolism | Phenols | Physiological aspects | Index Medicus
Journal Article
ACS applied materials & interfaces, ISSN 1944-8244, 01/2016, Volume 8, Issue 3, pp. 2348 - 2359
3D cell culture | nerve regeneration | self-assembling peptides | hydrogel | nanofiber | Science & Technology - Other Topics | Materials Science | Nanoscience & Nanotechnology | Technology | Materials Science, Multidisciplinary | Science & Technology | Molecular Sequence Data | Myelin Sheath - drug effects | Neural Stem Cells - cytology | Spectroscopy, Fourier Transform Infrared | Myelin Sheath - metabolism | Microscopy, Atomic Force | Circular Dichroism | Disease Models, Animal | Nanofibers - chemistry | Amino Acid Sequence | Cell Survival - drug effects | Green Fluorescent Proteins - metabolism | Nanofibers - ultrastructure | Peptides - chemistry | Protein Structure, Secondary | Rats, Transgenic | Neural Stem Cells - drug effects | Axons - drug effects | Models, Molecular | Rats, Sprague-Dawley | Peptides - pharmacology | Animals | Axons - pathology | Mice | Hydrogels - chemistry | Nerve Degeneration - drug therapy | Peptides - therapeutic use | Hydrogen-Ion Concentration | Index Medicus
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 03/2015, Volume 122, Issue 11, pp. 2200 - 2209
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Single-Blind Method | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Nerve Regeneration - physiology | Eye Infections - drug therapy | Male | Eye Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Corneal Ulcer - pathology | Eye Infections - parasitology | Adult | Corneal Ulcer - microbiology | Female | Trigeminal Nerve Diseases - pathology | Corneal Ulcer - parasitology | Eye Infections - pathology | Trigeminal Nerve - pathology | Nerve Degeneration - pathology | Corneal Ulcer - drug therapy | Microscopy, Confocal | Trigeminal Nerve - physiology | Cornea - innervation | Antiprotozoal Agents - therapeutic use | Physiological aspects | Keratitis | Microscope and microscopy | Analysis | Index Medicus
Journal Article
Experimental neurology, ISSN 0014-4886, 2007, Volume 206, Issue 1, pp. 59 - 69
Interleukin 6 | TNFα | Traumatic brain injury | Cerebral blood flow | Simvastatin | Nitric oxide | Atorvastatin | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Injuries of the nervous system and the skull. Diseases due to physical agents | Neurology | Biological and medical sciences | Medical sciences | Traumas. Diseases due to physical agents | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Cerebrovascular Circulation - physiology | Recovery of Function - drug effects | Male | Brain Injuries - physiopathology | RNA, Messenger - metabolism | Simvastatin - pharmacology | Chemotaxis, Leukocyte - physiology | Encephalitis - physiopathology | Chemotaxis, Leukocyte - drug effects | Anti-Inflammatory Agents - therapeutic use | Recovery of Function - physiology | Neurons - metabolism | Cytokines - genetics | Heptanoic Acids - pharmacology | Disease Models, Animal | Brain Edema - etiology | Anti-Inflammatory Agents - pharmacology | Endothelial Cells - metabolism | Brain Ischemia - physiopathology | Hippocampus - pathology | Cognition Disorders - drug therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Brain Edema - physiopathology | Brain Ischemia - drug therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Mice | Nerve Degeneration - etiology | Hippocampus - physiopathology | Encephalitis - etiology | Simvastatin - therapeutic use | Brain Injuries - drug therapy | Heptanoic Acids - therapeutic use | Nerve Degeneration - physiopathology | Hippocampus - drug effects | Encephalitis - drug therapy | Cognition Disorders - etiology | Neurons - drug effects | Pyrroles - therapeutic use | RNA, Messenger - drug effects | Cognition Disorders - physiopathology | Cerebrovascular Circulation - drug effects | Mice, Inbred C57BL | Treatment Outcome | Brain Ischemia - etiology | Atorvastatin Calcium | Pyrroles - pharmacology | Animals | Brain Edema - drug therapy | Brain Injuries - pathology | Nerve Degeneration - drug therapy | Endothelial Cells - drug effects | Physiological aspects | Brain | Injuries | Blood flow | Index Medicus
Journal Article
Frontiers in neuroendocrinology, ISSN 0091-3022, 2009, Volume 30, Issue 2, pp. 173 - 187
Endocrinology & Metabolism | Myelination | Spinal cord | Wobbler mouse | Neurodegeneration | Oligodendrocytes | Neuroactive steroid | Progesterone | Brain injury | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neuroprotective Agents - therapeutic use | Oligodendroglia - metabolism | Trauma, Nervous System - drug therapy | Trauma, Nervous System - pathology | Spinal Cord Injuries - drug therapy | Brain Injuries - drug therapy | Humans | Nerve Degeneration - physiopathology | Brain Injuries - physiopathology | Mice, Neurologic Mutants | Motor Neurons - pathology | Myelin Sheath - metabolism | Receptors, Progesterone - metabolism | Spinal Cord Injuries - pathology | Neuroprotective Agents - pharmacology | Oligodendroglia - drug effects | Motor Neurons - cytology | Brain-Derived Neurotrophic Factor - metabolism | Oligodendroglia - cytology | Motor Neurons - drug effects | Disease Models, Animal | Clinical Trials as Topic | Nerve Degeneration - pathology | Motor Neurons - metabolism | Trauma, Nervous System - physiopathology | Animals | Sex Factors | Mice | Spinal Cord Injuries - physiopathology | Brain Injuries - pathology | Nerve Degeneration - drug therapy | Brain | Messenger RNA | Metabolites | Physiological aspects | Peptide hormones | Growth factors | Injuries | Index Medicus
Journal Article